Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Chief Client Officer of $MRSH Sells 7,100 Shares

Automated

Martin South, the Chief Client Officer of $MRSH, sold 7,100 shares of the company on 07-28-2026 for an estimated $1,348,946. We received data on the trade from a recent SEC filing. This was a sale of approximately 29.9% of their shares of this class of stock. Following this trade, they now own 16,631 shares of this class of $MRSH stock.

$MRSH Insider Trading Activity

MRSH Insider Trades

$MRSH insiders have traded $MRSH stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $MRSH stock by insiders over the last 6 months:

  • JOHN Q DOYLE (President and CEO) has made 0 purchases and 2 sales selling 33,311 shares for an estimated $5,746,303.
  • LLOYD M YATES sold 12,000 shares for an estimated $2,107,800
  • MARTIN SOUTH (Chief Client Officer) sold 7,100 shares for an estimated $1,348,946
  • NICHOLAS MARK STUDER (President and CEO of OWG) sold 3,837 shares for an estimated $706,122
  • JOHN JUDE JONES (Chief Marketing Officer) sold 2,362 shares for an estimated $410,067

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$MRSH Hedge Fund Activity

We have seen 629 institutional investors add shares of $MRSH stock to their portfolio, and 763 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MRSH Congressional Stock Trading

Members of Congress have traded $MRSH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MRSH stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$MRSH Analyst Ratings

Wall Street analysts have issued reports on $MRSH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Cantor Fitzgerald issued a "Overweight" rating on 02/02/2026

To track analyst ratings and price targets for $MRSH, check out Quiver Quantitative's $MRSH forecast page.

$MRSH Price Targets

Multiple analysts have issued price targets for $MRSH recently. We have seen 12 analysts offer price targets for $MRSH in the last 6 months, with a median target of $201.5.

Here are some recent targets:

  • Yaron Kinar from Mizuho set a target price of $197.0 on 07/09/2026
  • Ryan Tunis from Cantor Fitzgerald set a target price of $218.0 on 07/09/2026
  • Brian Meredith from UBS set a target price of $212.0 on 07/08/2026
  • Bob Huang from Morgan Stanley set a target price of $175.0 on 07/06/2026
  • Paul Newsome from Piper Sandler set a target price of $182.0 on 05/26/2026
  • Matthew Heimermann from Citigroup set a target price of $200.0 on 05/06/2026
  • Meyer Shields from Keefe, Bruyette & Woods set a target price of $203.0 on 04/17/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles